This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Stocks in play: Satellos Bioscience Inc.
Announced the appointment of Wildon Farwell, M.D., MPH, as chief medical officer. Dr. Farwell joins Satellos from Dyne Therapeutics, where he most recently served as CMO and medical advisor. Satellos Bioscience Inc. shares T.MSCL are trading unchanged at $0.57.
